Concepts (156)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Parkinson Disease | 8 | 2023 | 272 | 4.040 |
Why?
|
| Neuropsychological Tests | 17 | 2021 | 517 | 1.970 |
Why?
|
| Saccades | 2 | 2017 | 17 | 0.970 |
Why?
|
| Attention | 6 | 2021 | 225 | 0.910 |
Why?
|
| Memory, Short-Term | 6 | 2018 | 79 | 0.880 |
Why?
|
| Executive Function | 2 | 2021 | 106 | 0.820 |
Why?
|
| Antiparkinson Agents | 1 | 2021 | 34 | 0.800 |
Why?
|
| Virtual Reality | 1 | 2021 | 13 | 0.750 |
Why?
|
| Gait Disorders, Neurologic | 1 | 2021 | 86 | 0.730 |
Why?
|
| Dopamine | 1 | 2021 | 474 | 0.660 |
Why?
|
| Cognitive Dysfunction | 2 | 2021 | 176 | 0.610 |
Why?
|
| Cognition | 5 | 2023 | 512 | 0.600 |
Why?
|
| Behavior Rating Scale | 1 | 2017 | 7 | 0.580 |
Why?
|
| Suicidal Ideation | 1 | 2016 | 106 | 0.490 |
Why?
|
| Photic Stimulation | 5 | 2018 | 229 | 0.480 |
Why?
|
| Fatty Acids, Omega-3 | 3 | 2021 | 41 | 0.460 |
Why?
|
| Sleep Deprivation | 2 | 2018 | 81 | 0.440 |
Why?
|
| Reaction Time | 3 | 2013 | 170 | 0.410 |
Why?
|
| Verbal Learning | 2 | 2013 | 29 | 0.410 |
Why?
|
| Motivation | 1 | 2016 | 561 | 0.410 |
Why?
|
| Mental Disorders | 3 | 2014 | 659 | 0.410 |
Why?
|
| United States Department of Veterans Affairs | 2 | 2013 | 307 | 0.400 |
Why?
|
| Huntington Disease | 1 | 2011 | 15 | 0.390 |
Why?
|
| Visual Perception | 3 | 2016 | 124 | 0.390 |
Why?
|
| Psychological Tests | 1 | 2011 | 96 | 0.390 |
Why?
|
| Heterozygote | 1 | 2011 | 174 | 0.380 |
Why?
|
| Dementia | 1 | 2012 | 158 | 0.380 |
Why?
|
| Mental Status and Dementia Tests | 2 | 2021 | 9 | 0.380 |
Why?
|
| Humans | 34 | 2023 | 68549 | 0.370 |
Why?
|
| Stress, Psychological | 1 | 2016 | 824 | 0.350 |
Why?
|
| Middle Aged | 19 | 2021 | 21119 | 0.340 |
Why?
|
| Amlodipine | 1 | 2009 | 31 | 0.340 |
Why?
|
| Facial Expression | 6 | 2004 | 36 | 0.340 |
Why?
|
| Adult | 24 | 2021 | 21379 | 0.330 |
Why?
|
| Calcium Channel Blockers | 1 | 2009 | 137 | 0.320 |
Why?
|
| Resilience, Psychological | 2 | 2021 | 43 | 0.320 |
Why?
|
| Female | 25 | 2021 | 38021 | 0.310 |
Why?
|
| Male | 25 | 2021 | 37283 | 0.300 |
Why?
|
| Cognition Disorders | 3 | 2018 | 342 | 0.300 |
Why?
|
| Aged | 13 | 2021 | 14842 | 0.300 |
Why?
|
| Frontal Lobe | 1 | 2009 | 156 | 0.300 |
Why?
|
| Severity of Illness Index | 4 | 2021 | 1851 | 0.300 |
Why?
|
| Dietary Supplements | 2 | 2021 | 331 | 0.270 |
Why?
|
| Speech Perception | 1 | 2009 | 261 | 0.260 |
Why?
|
| Reproducibility of Results | 6 | 2022 | 2077 | 0.260 |
Why?
|
| Vision Tests | 1 | 2005 | 18 | 0.260 |
Why?
|
| Contrast Sensitivity | 1 | 2005 | 28 | 0.250 |
Why?
|
| Computer Graphics | 1 | 2005 | 37 | 0.250 |
Why?
|
| Young Adult | 9 | 2021 | 5710 | 0.250 |
Why?
|
| Telemedicine | 1 | 2012 | 699 | 0.240 |
Why?
|
| Cocaine-Related Disorders | 1 | 2009 | 504 | 0.230 |
Why?
|
| Essential Tremor | 1 | 2022 | 8 | 0.210 |
Why?
|
| Emotions | 5 | 2004 | 244 | 0.210 |
Why?
|
| Time and Motion Studies | 1 | 2021 | 16 | 0.200 |
Why?
|
| Military Personnel | 2 | 2021 | 221 | 0.190 |
Why?
|
| Electronics | 1 | 2021 | 25 | 0.190 |
Why?
|
| Task Performance and Analysis | 1 | 2021 | 150 | 0.190 |
Why?
|
| Research Design | 2 | 2023 | 729 | 0.180 |
Why?
|
| Brain Mapping | 3 | 2013 | 531 | 0.170 |
Why?
|
| Veterans | 3 | 2018 | 904 | 0.170 |
Why?
|
| Psychometrics | 2 | 2022 | 514 | 0.160 |
Why?
|
| Sensitivity and Specificity | 2 | 2012 | 1753 | 0.150 |
Why?
|
| Emergency Service, Hospital | 2 | 2014 | 711 | 0.150 |
Why?
|
| Orientation, Spatial | 1 | 2016 | 2 | 0.140 |
Why?
|
| Agnosia | 1 | 2016 | 9 | 0.140 |
Why?
|
| Malingering | 1 | 2017 | 36 | 0.140 |
Why?
|
| Pattern Recognition, Visual | 3 | 2007 | 69 | 0.140 |
Why?
|
| Brain Injuries, Traumatic | 1 | 2018 | 105 | 0.140 |
Why?
|
| Disease Progression | 1 | 2020 | 1037 | 0.140 |
Why?
|
| Psychomotor Performance | 1 | 2018 | 213 | 0.140 |
Why?
|
| Treatment Outcome | 3 | 2021 | 7028 | 0.140 |
Why?
|
| Aged, 80 and over | 5 | 2018 | 4843 | 0.140 |
Why?
|
| United States | 7 | 2021 | 7338 | 0.140 |
Why?
|
| Sleep | 1 | 2018 | 263 | 0.130 |
Why?
|
| Veterans Health | 1 | 2016 | 62 | 0.130 |
Why?
|
| Stress Disorders, Post-Traumatic | 2 | 2018 | 1506 | 0.130 |
Why?
|
| Double-Blind Method | 3 | 2021 | 1738 | 0.120 |
Why?
|
| Magnetic Resonance Imaging | 5 | 2013 | 2222 | 0.120 |
Why?
|
| Psychiatric Status Rating Scales | 2 | 2017 | 782 | 0.120 |
Why?
|
| Hospitals, Psychiatric | 1 | 2014 | 59 | 0.120 |
Why?
|
| Health Resources | 1 | 2014 | 76 | 0.120 |
Why?
|
| Brain Injuries | 1 | 2017 | 268 | 0.110 |
Why?
|
| Memory Disorders | 2 | 2018 | 111 | 0.110 |
Why?
|
| Remote Consultation | 1 | 2012 | 50 | 0.100 |
Why?
|
| Models, Theoretical | 2 | 2013 | 384 | 0.100 |
Why?
|
| Models, Neurological | 1 | 2013 | 136 | 0.100 |
Why?
|
| Fixation, Ocular | 1 | 2011 | 13 | 0.100 |
Why?
|
| Patient Compliance | 1 | 2014 | 402 | 0.100 |
Why?
|
| Rural Health Services | 1 | 2012 | 101 | 0.100 |
Why?
|
| Quality of Health Care | 1 | 2014 | 322 | 0.100 |
Why?
|
| Hospitalization | 2 | 2014 | 977 | 0.090 |
Why?
|
| Feasibility Studies | 1 | 2012 | 652 | 0.090 |
Why?
|
| Individuality | 2 | 2007 | 44 | 0.090 |
Why?
|
| Cerebral Cortex | 1 | 2013 | 415 | 0.090 |
Why?
|
| Brain | 4 | 2004 | 2176 | 0.080 |
Why?
|
| Face | 1 | 2009 | 46 | 0.080 |
Why?
|
| Adolescent | 4 | 2016 | 8904 | 0.080 |
Why?
|
| Pilot Projects | 1 | 2012 | 1341 | 0.080 |
Why?
|
| Verbal Behavior | 1 | 2007 | 27 | 0.080 |
Why?
|
| Speech | 1 | 2009 | 118 | 0.080 |
Why?
|
| Schizophrenia | 1 | 2007 | 206 | 0.070 |
Why?
|
| Photography | 2 | 2004 | 37 | 0.070 |
Why?
|
| Motor Activity | 1 | 2009 | 621 | 0.070 |
Why?
|
| Neuropsychology | 1 | 2005 | 11 | 0.060 |
Why?
|
| Bipolar Disorder | 1 | 2007 | 307 | 0.060 |
Why?
|
| Outpatients | 2 | 2017 | 127 | 0.060 |
Why?
|
| Image Processing, Computer-Assisted | 2 | 2013 | 689 | 0.060 |
Why?
|
| Schizophrenic Psychology | 1 | 2003 | 53 | 0.060 |
Why?
|
| User-Computer Interface | 1 | 2005 | 230 | 0.060 |
Why?
|
| Affect | 1 | 2004 | 218 | 0.050 |
Why?
|
| Follow-Up Studies | 1 | 2009 | 3256 | 0.050 |
Why?
|
| Social Stigma | 1 | 2022 | 53 | 0.050 |
Why?
|
| Incidence | 2 | 2018 | 1582 | 0.050 |
Why?
|
| Phospholipids | 1 | 2021 | 108 | 0.050 |
Why?
|
| Time Factors | 1 | 2009 | 4655 | 0.050 |
Why?
|
| Memory | 1 | 2002 | 214 | 0.050 |
Why?
|
| Diagnostic and Statistical Manual of Mental Disorders | 2 | 2014 | 257 | 0.050 |
Why?
|
| Imaging, Three-Dimensional | 1 | 2002 | 333 | 0.040 |
Why?
|
| Memory, Episodic | 1 | 2018 | 10 | 0.040 |
Why?
|
| Sex Distribution | 1 | 2018 | 272 | 0.040 |
Why?
|
| Age Distribution | 1 | 2018 | 319 | 0.040 |
Why?
|
| Aging | 1 | 2003 | 911 | 0.040 |
Why?
|
| Hospitals, Veterans | 1 | 2017 | 147 | 0.030 |
Why?
|
| Regression Analysis | 1 | 2018 | 737 | 0.030 |
Why?
|
| Databases, Factual | 1 | 2018 | 621 | 0.030 |
Why?
|
| Disability Evaluation | 1 | 2017 | 298 | 0.030 |
Why?
|
| Suicide | 1 | 2016 | 115 | 0.030 |
Why?
|
| Surveys and Questionnaires | 1 | 2022 | 2798 | 0.030 |
Why?
|
| Comorbidity | 1 | 2018 | 1425 | 0.030 |
Why?
|
| Costs and Cost Analysis | 1 | 2014 | 193 | 0.030 |
Why?
|
| Retrospective Studies | 2 | 2018 | 7268 | 0.030 |
Why?
|
| Happiness | 2 | 2003 | 5 | 0.030 |
Why?
|
| Prognosis | 1 | 2018 | 2093 | 0.030 |
Why?
|
| Anger | 2 | 2003 | 47 | 0.030 |
Why?
|
| Statistics, Nonparametric | 1 | 2013 | 306 | 0.030 |
Why?
|
| Models, Psychological | 1 | 2013 | 180 | 0.030 |
Why?
|
| Risk Assessment | 1 | 2018 | 2004 | 0.030 |
Why?
|
| Fear | 2 | 2003 | 239 | 0.020 |
Why?
|
| Linear Models | 1 | 2013 | 521 | 0.020 |
Why?
|
| Oxygen | 1 | 2013 | 386 | 0.020 |
Why?
|
| Analysis of Variance | 1 | 2013 | 1040 | 0.020 |
Why?
|
| Predictive Value of Tests | 1 | 2013 | 1465 | 0.020 |
Why?
|
| Nonverbal Communication | 1 | 2004 | 4 | 0.020 |
Why?
|
| Discrimination Learning | 1 | 2004 | 45 | 0.020 |
Why?
|
| Reference Values | 1 | 2004 | 579 | 0.010 |
Why?
|
| Limbic System | 1 | 2003 | 106 | 0.010 |
Why?
|
| Students | 1 | 2004 | 233 | 0.010 |
Why?
|
| Parietal Lobe | 1 | 2002 | 59 | 0.010 |
Why?
|
| Neurosciences | 1 | 2002 | 15 | 0.010 |
Why?
|
| Temporal Lobe | 1 | 2003 | 125 | 0.010 |
Why?
|
| Organ Specificity | 1 | 2002 | 167 | 0.010 |
Why?
|
| Functional Laterality | 1 | 2002 | 240 | 0.010 |
Why?
|
| Random Allocation | 1 | 2002 | 442 | 0.010 |
Why?
|
| Sex Factors | 1 | 2004 | 1265 | 0.010 |
Why?
|
| Prefrontal Cortex | 1 | 2002 | 639 | 0.010 |
Why?
|
| Child | 1 | 2002 | 6401 | 0.010 |
Why?
|